PureLift Pro Plus or Bio-Therapeutic bt-sculpt GEN2, What Professional Grade Means
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, kinésithérapeute, DPT
Doctorat en physiothérapie (DPT), physiothérapeute agréé (PT)
Read bio
Le Dr Andrew Conrad Barile est docteur en physiothérapie et PDG ainsi que fondateur de Xtreem Pulse LLC. Il a obtenu son doctorat en physiothérapie à Daemen College et possède plus de vingt ans d'expérience clinique et entrepreneuriale en physiothérapie pédiatrique, thérapie craniosacrale et innovation en dispositifs médicaux. Sa profonde connaissance de l'anatomie humaine, de la physiologie musculaire et des technologies thérapeutiques offre une approche scientifique précieuse pour le rajeunissement du visage et les solutions anti-âge.
Bertica M. Rubio, M.D.
Directeur Médical, Clinique de Médecine Régénérative Anti-âge | Médecin Certifié par le Conseil | École de Médecine de Dartmouth
Read bio
Le Dr Bertica M. Rubio est une médecin certifiée et directrice médicale de la clinique de médecine régénérative anti-âge à Redlands, en Californie. Elle a obtenu son Bachelor of Science à l'Université Loyola Marymount et son Doctorat en médecine à la Dartmouth Medical School (Geisel School of Medicine). Elle a effectué sa résidence en pédiatrie au UC Irvine Medical Center.
Forte de plusieurs décennies d'expérience clinique, le Dr Rubio est spécialisée en médecine de gestion du vieillissement, médecine régénérative, cicatrisation des plaies et thérapies par facteurs de croissance. Sa pratique intègre la science médicale fondée sur des preuves avec des traitements esthétiques et régénératifs avancés, aidant les patients à atteindre une santé optimale et une vitalité juvénile.
Le Dr Rubio est passionnée par l'éducation des patients sur la science derrière les soins de la peau, le rajeunissement du visage et les technologies non invasives comme l'EMS (stimulation électrique musculaire) pour le tonus facial. Ses articles pour PureLift LAB allient connaissances médicales rigoureuses et conseils pratiques pour obtenir des résultats réels et durables.
Daniel Grinberg, MD, FACS
Otolaryngologiste et chirurgien de la tête et du cou certifié par le conseil | Membre, American College of Surgeons | Professeur clinique adjoint, Mount Sinai School of Medicine
Read bio
Daniel Grinberg, MD, FACS, est un oto-rhino-laryngologiste certifié par le conseil et chirurgien de la tête et du cou chez ENT and Allergy Associates à West Nyack, NY. Il a obtenu son diplôme de médecine au Columbia University College of Physicians and Surgeons, a effectué sa résidence en oto-rhino-laryngologie au New York University Medical Center, et est professeur clinique adjoint à la Mount Sinai School of Medicine. Il est membre de l'American College of Surgeons et de l'American Academy of Otolaryngology.
La perspective chirurgicale de la tête et du cou du Dr Grinberg offre aux lecteurs de PureLift LAB une vision clinique élargie — reliant la pratique EMS à domicile à l'anatomie médicale sous-jacente avec la même rigueur scientifique que celle que nous appliquons à chaque spécification d'appareil.
Prof. Dr med Ivo Buschmann
Président d'Angiologie, Hochschule Medizinische Brandenburg | Directeur de clinique, Clinique universitaire d'angiologie, Hôpital universitaire de Brandebourg | Ancien consultant principal, Charité Universitätsmedizin Berlin
Read bio
Le Prof. Dr. med. Ivo Buschmann est titulaire de la chaire d'angiologie à la Medizinische Hochschule Brandenburg Theodor Fontane (MHB) et directeur de la clinique universitaire d'angiologie à l'hôpital universitaire de Brandebourg. Il a effectué sa formation médicale à l'Université de Hambourg, a été boursier de la Société Max-Planck à l'Institut Max-Planck de recherche sur le cœur et les poumons, et a occupé des postes de consultant principal à la Charité Universitätsmedizin Berlin Campus Virchow avant d'être nommé titulaire de la chaire à la MHB en 2016.
Le Prof. Buschmann est l'une des principales autorités européennes en arteriogenèse — la croissance et le remodelage des vaisseaux sanguins induits par le flux — avec plus de 150 publications évaluées par des pairs et plusieurs brevets américains et européens sur des dispositifs stimulant la croissance des vaisseaux collatéraux par une thérapie contrôlée du taux de cisaillement. Ses recherches relient la stimulation mécanique et électrique à l'adaptation vasculaire, à la microcirculation et à la perfusion tissulaire.
Les contributions du Prof. Buschmann apportent aux lecteurs de PureLift LAB une perspective en biologie vasculaire qui complète notre expertise clinique, en physiothérapie et en anatomie chirurgicale — expliquant comment la stimulation EMS engage non seulement les muscles faciaux mais aussi la microcirculation qui les alimente, et pourquoi une administration intelligente est aussi importante au niveau du flux sanguin qu'à celui de la contraction musculaire.
Partager
Bio-Therapeutic is one of the oldest names in professional microcurrent, and it publishes no output figure for the bt-sculpt anywhere we could find.
This article compares the two on what decides the result you actually see, such as:
- what a 510(k) Statement means for what you can look up
- why the device is sub-sensory by design rather than by accident
- the wording on their page that does not match the paperwork
- what fifty years of treatment-room experience genuinely buys
- where a $899 handheld does something their device does not
and many more!
This is a comparison with a serious company, and the disagreement is about disclosure rather than about competence.
Key Points:
The bt-sculpt GEN2 is priced behind a professional login, and the company's own launch release put it on Amazon at $395.
Bio-Therapeutic publishes no microamp, milliamp, frequency or waveform figure for the device, only the phrase frequency specific Suzuki Sequencing and five power levels.
Its clearances exist, filed by parent company Micro Current Technology of Seattle, including K252218 and K233525, as 510(k) Statements rather than Summaries, so no specification document is public.
Bio-Therapeutic describes its own microcurrent as sub-sensory and imperceptible, and treats muscle fatigue as a failure mode rather than a goal.
PureLift Pro Plus is $899, publishes 9 mA at 500 ohms with a 4 microsecond pulse width, and is cleared under K221443.
Who Bio-Therapeutic is
The company has been building microcurrent equipment since 1974 and its devices are in treatment rooms worldwide.
The bt-sculpt GEN2 is the handheld version of that lineage, with a self-tensioning probe and pre-programmed sequences drawn from decades of protocol work.
That history is worth something real, and a practitioner buying into a system with training and service behind it is making a sensible purchase.
None of what follows is an argument that the device is poorly made.
Why there is nothing to look up
A 510(k) can be filed as a Summary, which publishes a specification, or as a Statement, which does not.
Bio-Therapeutic's filings are Statements, so there is no public document giving output, frequency or waveform.
Combined with a product page that publishes no figures either, the result is that a buyer has no number to check, at any price point, from any source.
We have written separately about why an output figure without its measurement conditions is not a specification, and this is the more extreme case: no figure at all.
The wording worth checking
The bt-sculpt product page describes the device as the FDA approved bt-sculpt GEN2, and the site carries a footer badge reading FDA Registered Medical Device Manufacturer.
Approved is the wrong word for any device in this class, because approval is a pathway reserved for higher-risk devices and no facial toning device goes through it.
Registered describes a factory on a list rather than a review of the device.
The clearances are real, so this is a wording problem rather than a missing-paperwork problem, and we set out how to check any brand's status in our guide to the 510(k) search.
Sub-sensory by design
Bio-Therapeutic states that its microcurrent is sub-sensory, which means it is imperceptible, and warns elsewhere against equipment delivering excessive current that can fatigue facial muscles.
That is a coherent philosophy and it is shared across the professional microcurrent world, with 7E Wellness saying the same about its own devices.
It also means no setting on the device contracts a muscle, which is the thing a buyer hoping for visible lifting most needs to understand.
Kwak's split-face work found the microcurrent side improved eye-wrinkle volume and dermal density while the EMS side improved lifting measures (10.52660/jksc.2023.29.6.1505), which is the cleanest demonstration that neither band replaces the other.
What Pro Plus adds
Pro Plus carries seven technologies on one dial: Infusion, iontophoresis, nanocurrent at level 1, microcurrent at level 2, EMS from level 3, PDM and PDM++, the bipolar pulse, with the diamond-faceted probe.
Levels 1 and 2 put you in the same band the bt-sculpt occupies, so nothing is given up by adding the eight levels above it.
Pro Plus reaches 9 mA at 500 ohms, the strongest output in our range, and runs on any water-based serum rather than a proprietary conductor.
It is cleared under K221443 and made in Japan in an ISO 13485 facility that has been building medical devices since 1987.
Which to buy
Buy the bt-sculpt if you are a practitioner invested in the Bio-Therapeutic system, if the protocol library and the support matter to you, and if sub-sensory work is what you want to deliver.
Buy PureLift Pro Plus if you want both bands in one device and want the output published at a stated load so you can compare it with anything else.
If you run a treatment room, the two are complementary rather than competing, since the muscle band is a service a microcurrent machine does not offer.
This comparison sits inside our full map of the category, where we set out all 33 devices we track, what each one carries and what each brand publishes: Nine Technologies on One Dial, What the Rest of the Market Actually Carries.
Prices, specifications and clearance records verified on 21 September 2026 against each brand's own published material and the FDA 510(k) database.